Uptake of seven myocardial tracers during increased myocardial blood flow by dobutamine infusion

Investigative Radiology

Volumn 34, Issue 2, 1999, Pages 91-98

  Rosenbaum, Abbe F ^a   McGoron, Anthony J ^a   Millard, Ronald W ^a   Gabel, Marjorie ^a   Biniakiewicz, Danuta ^a   Walsh, Richard A ^a   Gerson, Myron C ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Dobutamine; Myocardium; Perfusion; Radiotracer

Indexed keywords

DOBUTAMINE; TECHNETIUM 99M; THALLIUM 201;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG DISTRIBUTION; DRUG UPTAKE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; MALE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0032985649     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199902000-00001     Document Type: Article

References (24)

1. Beller GA, Holzgrefe HH, Watson DD. Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201. Circulation 1983;68:1328-1338.
2. Chu A, Murdock RH Jr, Cobb FR. Relation between regional distribution of thallium-201 and myocardial blood flow in normal, acutely ischemic, and infarcted myocardium. Am J Cardiol 1982; 50:1141-1144.
3. Glover DK, Okada RD. Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. Circulation 1990;81:628-636.
4. Sinusas AJ, Shi QX, Saltzberg MT, Vitols P, Jain D, Wackers FJTh, Zaret BL. Technetium-99m-tetrofosmin to assess myocardial blood flow: Experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35:664-671.
5. 99mTc-Q12 in canine myocardium. Circulation 1994;89:1291-1300.
6. Gerson MC, Millard RW, McGoron AJ, et al. Myocardial uptake and kinetic properties of technetium-99m-Q3 in dogs. J Nucl Med 1994;35:1698-1706.
7. Ghezzi C, Fagret D, Arvieux CC, et al. Myocardial kinetics of TcN-NOET: A neutral lipophilic complex tracer of regional myocardial blood flow. J Nucl Med 1995;36:1069-1077.
8. Chatterjee K. Effects of dobutamine on coronary hemodynamics and myocardial energetics. In: Chatterjee K, ed. Dobutamine: A Ten-Year Review. NCM Publishers, Inc., New York, NY, 1989;49-67.
9. 99mTc perfusion tracers in a canine model of myocardial ischemia. J Nucl Med 1997;38:1847-1856.
10. Heymann MA, Payne BD, Hoffman JIE, Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis 1977;20:55-79.
11. 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 1995;91: 813-820.
12. Gosselin RE, Stibitz GR. Rates of solute absorption from tissue depots: Theoretical considerations. Pflugers Arch 1970;318:85-98.
13. Nielsen AP, Morris KG, Murdock R, Bruno FP, Cobb FR. Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise. Circulation 1980;61:797-801.
14. Okada RD. Myocardial kinetics of thallium-201 after stress in normal and perfusion-reduced canine myocardium. Am J Cardiol 1985;56: 969-973.
15. Mousa SA, Cooney JM, Williams SJ. Regional myocardial distribution of RP-30 in animal models of myocardial ischemia and reperfusion (Abstr). J Nucl Med 1987;28(4):620.
16. Sinusas AJ, Watson DD, Cannon JM Jr, Beller GA. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol 1989;14:1785-1793.
17. Hays J, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993;21:1583-1590.
18. Calnon DA, Glover DK, Beller GA, et al. Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenosis. Circulation 1997;96:2353-2360.
19. Wu JC, Yun JJ, Heller EN, et al. Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: Implications for technetium-99m-sestamibi imaging. J Nucl Med 1998:38:417-425.
20. Vanzetto G, Calnon DA, Ruiz M, et al. Myocardial uptake and redistribution of 99mTc-N-Noet in dogs with either sustained coronary low flow or transient coronary occlusion. Circulation 1997; 96:2325-2331.
21. Leon AR, Eisner RL, Martin SE, et al. Comparison of single-photon emission computed tomographic (SPECT) myocardial perfusion imaging with thallium-201 and technetium-99m sestamibi in dogs. J Am Coll Cardiol 1992;20:1612-1625.
22. Maublant JC, Marcaggi X, Lusson J-R, et al. Comparison between thallium-201 and technetium-99m methoxyisobutyl isonitrile defect size in single-photon emission computed tomography at rest, exercise and redistribution in coronary artery disease. Am J Cardiol 1992;69:183-187.
23. Narahara KA, Villanueva-Meyer J, Thompson CJ, Brizendine M, Mena I. Comparison of thallium-201 and technetium-99m hexakis 2-methoxyisobutyl isonitrile single-photon emission computed tomography for estimating the extent of myocardial ischemia and infarction in coronary artery disease. Am J Cardiol 1990;66:1438-1444.
24. Matsunari I, Fujino S, Taki J, et al. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease. Am J Cardiol 1996;77:350-354.